PhRMA
MARCH 27, 2023
It’s been over three years since I saw my first COVID-19 patient in the emergency department. The image of that x-ray is burned into my memory: clusters of white spots spread out across both sides of the patient’s lung. A dramatic, and not all that common, clinical finding. The patient in front of me already had a fever and was breathing quickly, in need of extra oxygen support.
Drug Topics
MARCH 27, 2023
The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MARCH 27, 2023
A report has predicted the rapid microbiology testing market size is estimated to grow at a compound annual growth rate (CAGR) of 9.31 percent between 2022 and 2027. According to the data, the market is forecasted to increase by $2,487.91 million. The research includes historic market data from 2017 to 2021, using 2022 as the base year. It covers various testing methods such as growth-based, nucleic-acid-based and viability-based.
Drug Topics
MARCH 27, 2023
Drug Topics® is joined by Thomas W. Taylor, the owner of Williamsburg Drug, for a conversation about starting an independent pharmacy, maintaining patient relationships, and more.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MARCH 27, 2023
Public health workers will soon have a new tool at their disposal to thwart a spreading danger to users of illicit drugs: xylazine test strips. The new testing kits will allow health departments, grassroots harm-reduction groups, and individual drug users to test substances for the presence of xylazine, a sedative often referred to as “tranq.
Drug Topics
MARCH 27, 2023
As a GPO member, how many hours a week do you eat up in purchasing? You can unify purchasing and inventory into one integrated solution with best-in-class automation. It won’t replace your GPO — it works with your system giving you greater visibility, accountability, insight, convenience and efficiency.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
MARCH 27, 2023
Smarter Inventory for GPO Members: Maximize Your GPO Membership If you’re working with a GPO, best-in-class inventory automation gives your pharmacy more inventory options, more insights into that relationship and more oversight of your wholesaler. It won’t replace your GPO. It empowers you. It integrates with your GPO—and your entire vendor portfolio—to give you visibility, accountability and insight.
The Checkup by Singlecare
MARCH 27, 2023
Just like their human best friends, dogs can feel anxious and even depressed sometimes. Also like humans, the medication trazodone is sometimes prescribed for dogs who aren’t their usual happy selves. In humans, this medication treats depression and insomnia —thanks to its sedative effects. Here is what you should know about using this Rx in veterinary medicine, including its use, dosage, and side effects.
Drug Topics
MARCH 27, 2023
Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.
Hospital Pharmacy Europe
MARCH 27, 2023
Undertaking lifelong endurance exercise gives rise to more risk-prone non-calcified coronary plaques compared to fit and healthy individuals The findings of a prospective study by the Master@Heart Consortium has revealed that participation in lifelong endurance exercise, gives rise to a more unfavourable coronary plaque profile compared to healthy and active non-athletes.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
MARCH 27, 2023
Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.
Pharmaceutical Technology
MARCH 27, 2023
Regenerative medicines in early-stage development (preclinical, discovery, or investigational new drug [IND]/ clinical trial application [CTA] filed status) have seen a change in drug targets compared to therapies in late-stage development (Phase II to pre-registration stage). According to GlobalData’s Drugs database, early-stage therapies are focused on vascular endothelial growth factor (VEGF) as the top drug target, with three drugs currently in development.
STAT
MARCH 27, 2023
DALLAS — Inside Kelly Eakin’s garage in suburban Maryland, two of the world’s smallest wheelchairs gather dust. Just a few years ago, these wheelchairs were in high demand. There was a constant waiting list of eight or nine young children with spinal muscular atrophy, or SMA, a devastating disease that could shorten life and stunt growth so severely many patients couldn’t use the child wheelchairs insurance covered.
DiversifyRx
MARCH 27, 2023
Get insider secrets on improving your independent pharmacy’s cash flow. Improving your pharmacy’s cash flow is more critical than ever before! There are so many threats to your business. From the 2024 DIR fee apocalypse to aggressive audits to dwindling profits. Now is the time to shore up your cash flow so you can sleep well at night. Here are my tried and true secrets to improving pharmacy cash flow.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MARCH 27, 2023
The Food and Drug Administration will convene a meeting of independent advisers to review a personalized cell therapy for ALS that the agency has previously refused to consider. On Monday, BrainStorm Cell Therapeutics, maker of the experimental ALS treatment called NurOwn, said the FDA had agreed to hold an advisory committee meeting. A date has not been set.
Fierce Healthcare
MARCH 27, 2023
ViVE 2023: UnitedHealth's new tech exec on how the payer giant is aiming to accelerate transformation pminemyer Mon, 03/27/2023 - 22:48
STAT
MARCH 27, 2023
This article is excerpted from the latest STAT Report: Treating Depression: a new era of promising Drugs. O n May 8, 1972, a researcher at Eli Lilly in Indianapolis named Jong-Sin Horng tested a compound his team had developed and found it had a curious property.
Hospital Pharmacy Europe
MARCH 27, 2023
Increased ozone levels within the atmosphere are associated with an greater risk of hospital admission for a range of cardiovascular diseases An increased level of atmospheric ozone has been shown to be associated with a greater risk of hospital admission for a number of adverse cardiovascular events according to the findings of a time-series analysis by Chinese researchers.
STAT
MARCH 27, 2023
The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers of fixing prices for various medicines, the latest effort to scrutinize the controversial companies that occupy a crucial role in pharmaceutical pricing. The lawsuit alleges Humana, Prime Therapeutics, and Cigna — which owns Express Scripts — shared pricing information and other data gathered by a company based in Switzerland to gain an upper hand in negotiations with drug companies f
Drug Store News
MARCH 27, 2023
Mike Stigers will succeed Joe Sheridan, who announced his retirement last year and will remain with the company through the end of the calendar year.
STAT
MARCH 27, 2023
When Moderna CEO Stéphane Bancel was called before a Senate committee last week to defend his company’s decision to raise the price of its Covid vaccine, things went largely as one would expect. Progressives tried to pin the Moderna billionaire down as a symbol of corporate greed. Mitt Romney delivered a paean to the free market. And Bancel tried — and succeeded — at not being too quotable, showing what appeared to be a newfound restraint.
Fierce Pharma
MARCH 27, 2023
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries esagonowsky Mon, 03/27/2023 - 09:19
Drug Store News
MARCH 27, 2023
The limited-edition cereal features Frosted Flakes and green squares of “Creeper Bit” marshmallows that evoke Minecraft’s pixelated block look.
Fierce Pharma
MARCH 27, 2023
BioNTech surprises analysts with low revenue guidance as COVID-19 vaccine demand wavers fkansteiner Mon, 03/27/2023 - 09:35
The People's Pharmacy
MARCH 27, 2023
Do you suffer from heartburn? Many people do, judging from the popularity of acid-suppressing drugs such as esomeprazole ( Nexium ), lansoprazole ( Prevacid ) or omeprazole ( Prilosec ). Antacids like Maalox or Tums also sell briskly. But readers have found a lot of non-drug alternatives that can ease the burn. Some swear by pre-emptively munching a small handful of almonds at the end of a meal.
Fierce Healthcare
MARCH 27, 2023
Value-based care enabler Wellvana clinches $84M to expand in existing, new markets agliadkovskaya Mon, 03/27/2023 - 14:48
Fierce Pharma
MARCH 27, 2023
Duo no more: After M&A spree, Pfizer parts ways with Merck KGaA on Bavencio zbecker Mon, 03/27/2023 - 17:42
STAT
MARCH 27, 2023
Novartis announced data Monday that could set up one of the biggest marketing battles in cancer. At issue is the market for medicines called CDK 4/6 inhibitors. The first of these drugs, Pfizer’s Ibrance, is a $5-billion-a-year product and one of that company’s top sellers. But it has been losing market share to Eli Lilly’s Verzenio.
Fierce Pharma
MARCH 27, 2023
With FDA nod for a Novartis castoff, Pharming is set to market a second rare disease drug kdunleavy Mon, 03/27/2023 - 10:40
STAT
MARCH 27, 2023
A recent high-profile paper suggesting that science is becoming dramatically less disruptive set the academic world abuzz. One interpretation of this finding — though by no means the only one — is that the exponential growth of the scientific literature has led researchers to build off older and increasingly narrow slices of the research landscape.
Drug Store News
MARCH 27, 2023
DSN’s Retail Excellence Awards spotlight companies that help consumers treat minor maladies with over-the-counter solutions.
Fierce Pharma
MARCH 27, 2023
In new PD-1 showdown, GSK's Jemperli loses initial edge on Merck's Keytruda aliu Mon, 03/27/2023 - 15:40
BioPharm
MARCH 27, 2023
As the therapeutic landscape grows more complex, so too must the analytical techniques for cleaning validation to ensure the utmost cleanliness is achieved.
Fierce Healthcare
MARCH 27, 2023
ViVE 2023: Hospitals, health tech companies face shortages in data privacy, security talent.
Expert insights. Personalized for you.
214 
Let's personalize your content